UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000020931
Receipt No. R000024149
Official scientific title of the study Intragastric injection of botulinum toxin A for the treatment of obesity
Date of disclosure of the study information 2016/03/01
Last modified on 2017/12/20 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Intragastric injection of botulinum toxin A for the treatment of obesity
Title of the study (Brief title) Intragastric injection of botulinum toxin A for the treatment of obesity
Region
Japan

Condition
Condition obesity
Classification by specialty
Gastroenterology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Efficacty and safety of intragastric injection of botulinum toxin A for the treatment of obesity
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Weight loss after 24 weeks
Key secondary outcomes Incidence of complications

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine Maneuver
Interventions/Control_1 Injections were performed via 25G EUS needle under real-time EUS guidance,targeting the gastric muscularis propria by 20 U in ten places
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
75 years-old >=
Gender Male and Female
Key inclusion criteria Patient with more than BMI30
Key exclusion criteria 1, myasthenia gravis, Lambert-Eaton syndrome, amyotrophic lateral sclerosis
2, Patient with the high breathing disorder
3, Pregnant woman, woman with the possibility of the pregnancy,nursing girl
Target sample size 30

Research contact person
Name of lead principal investigator Jin Kan Sai
Organization Juntendo University Hospital
Division name Department of Gastroenterology
Address 3-1-3 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
TEL 03-3813-3111(70227)
Email jinkans@juntendo.ac.jp

Public contact
Name of contact person Ryo Kanazawa
Organization Juntendo University Hospital
Division name Department of Gastroenterology
Address 3-1-3 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
TEL 03-3813-3111(70226)
Homepage URL
Email rkanaza@juntendo.ac.jp

Sponsor
Institute Juntendo University Hospital
Department of Gastroenterology
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 03 Month 01 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2015 Year 12 Month 23 Day
Anticipated trial start date
2016 Year 03 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 02 Month 08 Day
Last modified on
2017 Year 12 Month 20 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024149